Low-dose spiruchostatin-B, a potent histone deacetylase inhibitor enhances radiation-induced apoptosis in human lymphoma U937 cells via modulation of redox signaling-Reference-Cited by-同舟云学术

Low-dose spiruchostatin-B, a potent histone deacetylase inhibitor enhances radiation-induced apoptosis in human lymphoma U937 cells via modulation of redox signaling

Published:2016-04-24 Issue:6 Volume:50 Page:596-610
ISSN:1071-5762
Container-title:Free Radical Research
language:en
Short-container-title:Free Radical Research

Author:

Rehman Mati Ur¹,Jawaid Paras¹,Zhao Qing Li¹,Li Peng¹,Narita Koichi²,Katoh Tadashi²,Shimizu Tadamichi³,Kondo Takashi¹

Affiliation:

1. Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan;

2. Laboratory of Synthetic and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tohoku Pharmaceutical University, Aoba-ku, Sendai, Japan;

3. Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.3109/10715762.2015.1115029

Reference45 articles.

1. FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.

2. Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

3. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

4. Cardiotoxicity of Histone Deacetylase Inhibitor Depsipeptide in Patients with Metastatic Neuroendocrine Tumors

5. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC-an important target for improving tumor radiotherapy resistance;Frontiers in Oncology;2023-07-12

2. From a Better Understanding of the Mechanisms of Action of Histone Deacetylases Inhibitors to the Progress of the Treatment of Malignant Lymphomas and Plasma Cell Myeloma;Recent Patents on Anti-Cancer Drug Discovery;2017-11-20

3. Cold atmospheric helium plasma causes synergistic enhancement in cell death with hyperthermia and an additive enhancement with radiation;Scientific Reports;2017-09-15